HSBC Holdings’s Evolus EOLS Stock Holding History

HSBC Holdings’s Portfolio EOLS Stock Details EOLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$227K	Sell	32,423 -1,865	-5%	-$11K	﹤0.01%	2644
2026 Q1	$142K	Buy	+34,288	New	+$166K	﹤0.01%	2695
2022 Q4	–	Sell	-12,256	Closed	-$98K	–	3075
2022 Q3	$98K	Sell	12,256 -92,452	-88%	-$980K	﹤0.01%	2747
2022 Q2	$1.21M	Buy	+104,708	New	+$1.24M	﹤0.01%	1823
2022 Q1	–	Sell	-10,561	Closed	-$69K	–	3313
2021 Q4	$69K	Buy	+10,561	New	+$72.5K	﹤0.01%	3182
2021 Q1	–	Sell	-18,507	Closed	-$62K	–	2836
2020 Q4	$62K	Buy	+18,507	New	+$69.5K	﹤0.01%	2978
2019 Q4	–	Sell	-11,834	Closed	-$185K	–	3077
2019 Q3	$185K	Sell	11,834 -3,003	-20%	-$49.2K	﹤0.01%	2886
2019 Q2	$217K	Buy	+14,837	New	+$294K	﹤0.01%	2505

Other funds holding EOLS

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

HSBC Holdings's EOLS Position: Q2 2026 in Review

HSBC Holdings reduced its Evolus (EOLS) stake by 5.4% in Q2 2026, selling an estimated $11K and leaving 32,423 shares worth $227K. The position accounts for ﹤0.01% of the portfolio, ranked #2644.

HSBC Holdings first reported a position in EOLS in Q2 2019 and has held it in 8 quarters since. The position peaked at $1.21M in Q2 2022. 159 funds tracked by Wall St. Rank hold EOLS as of Q2 2026.

HSBC Holdings held 32,423 shares of Evolus worth $227K as of Q2 2026.
HSBC Holdings sold 1,865 Evolus shares in Q2 2026, an estimated $11K.
Evolus made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2644 holding.
HSBC Holdings first reported a position in Evolus in Q2 2019 and has held it in 8 quarters since.
HSBC Holdings's Evolus position peaked at $1.21M in Q2 2022.
159 funds tracked by Wall St. Rank held Evolus as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.